Cambridge Investment Research Advisors’s Macerich MAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,128
Closed -$203K 3552
2024
Q3
$203K Buy
11,128
+15
+0.1% +$236 ﹤0.01% 3142
2024
Q2
$172K Sell
11,113
-8,362
-43% -$128K ﹤0.01% 3079
2024
Q1
$336K Sell
19,475
-8,189
-30% -$134K ﹤0.01% 2615
2023
Q4
$427K Sell
27,664
-12,903
-32% -$154K ﹤0.01% 2321
2023
Q3
$443K Sell
40,567
-764
-2% -$9.12K ﹤0.01% 2187
2023
Q2
$466K Buy
41,331
+2,263
+6% +$23K ﹤0.01% 2189
2023
Q1
$414K Buy
39,068
+1,251
+3% +$14.9K ﹤0.01% 2227
2022
Q4
$426K Buy
37,817
+10,899
+40% +$123K ﹤0.01% 2144
2022
Q3
$214K Sell
26,918
-792
-3% -$7.69K ﹤0.01% 2642
2022
Q2
$241K Buy
27,710
+1,293
+5% +$15.6K ﹤0.01% 2567
2022
Q1
$413K Buy
26,417
+4,253
+19% +$68.2K ﹤0.01% 2263
2021
Q4
$383K Buy
22,164
+3,043
+16% +$57K ﹤0.01% 2319
2021
Q3
$320K Buy
19,121
+1,092
+6% +$18.5K ﹤0.01% 2407
2021
Q2
$329K Buy
18,029
+2,597
+17% +$38.9K ﹤0.01% 2392
2021
Q1
$181K Buy
+15,432
New +$206K ﹤0.01% 2658

Other funds holding MAC

Cambridge Investment Research Advisors's MAC Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of Macerich (MAC) in Q4 2024, closing a stake of 11,128 shares — an estimated $203K sold.

Cambridge Investment Research Advisors first reported a position in MAC in Q1 2021 and held it in 15 quarters. The position peaked at $466K in Q2 2023. 291 funds tracked by Wall St. Rank hold MAC as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining Macerich position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,128 Macerich shares in Q4 2024, an estimated $203K.
  • Cambridge Investment Research Advisors first reported a position in Macerich in Q1 2021 and held it in 15 quarters.
  • Cambridge Investment Research Advisors's Macerich position peaked at $466K in Q2 2023.
  • 291 funds tracked by Wall St. Rank held Macerich as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.